SCHEMBL8340484

SCHEMBL8340484

NC(N)=NC(=O)c1ccn(-c2nccc3ccccc23)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
COMT P21964 1/20 0.55
PLAU P00749 4/20 0.42
PLG P00747 2/20 0.42
SLC9A1 P19634 4/20 0.37
HRH4 Q9H3N8 1/20 0.36
HTR2C P28335 1/20 0.36
SLC9A2 Q9UBY0 1/20 0.36
HTR2B P41595 2/20 0.36
HTR7 P34969 1/20 0.36
NCOA3 Q9Y6Q9 1/20 0.36
NPC1 O15118 1/20 0.35
ALDH1A1 P00352 1/20 0.35
MAPT P10636 1/20 0.35
RAB9A P51151 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
F12 P00748 1/20 0.35
NCF1 P14598 1/20 0.35
NOS3 P29474 1/20 0.35
NOS1 P29475 1/20 0.35
NOS2 P35228 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6082267 0.82 COMT (0.63) COMTHRH4HTR2CNCOA3NPC1
Hydrochloric Acid SCHEMBL6081824 0.80 COMT (0.60) COMTPLAUHRH4HTR2CNCOA3
SCHEMBL6081364 0.80 COMT (0.54) COMTPLAUPLGHRH4HTR2C
Hydrochloric Acid SCHEMBL6082398 0.79 COMT (0.53) COMTPLAUPLGHRH4HTR2C
SCHEMBL8339628 0.78 SLC9A1 (0.46) PLAUSLC9A1SLC9A2HTR2BHTR7
SCHEMBL6082179 0.78 COMT (0.57) COMTHRH4HTR2CNCOA3NPC1
SCHEMBL8347760 0.75 PLAU (0.44) COMTPLAUPLGSLC9A1HRH4
SCHEMBL8338997 0.72 HTR5A (0.41) SLC9A1HTR2BHTR7
SCHEMBL8337393 0.71 NCF1 (0.45) SLC9A1MAPTNCF1
SCHEMBL8346321 0.69 SLC9A1 (0.40) COMTPLAUPLGSLC9A1HRH4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004007478-A2 DERIVATIVES OF 3-GUANIDINOCARBONYL-1-HETEROARYL-PYRROLE, PROCESS FOR THEIR PREPARATION AND THEIR PHARMACEUTICAL USE AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2004-01-22 WO disclosed